Columbia Care (CSE: CHWF, OTC: CHWBF): The Next 35% Gain in 2 Days?

Mergers and acquisitions (M&A) continue to heat up in the cannabis sector. This is a trend that investors need to know about because it’s creating an opportunity to pick up a quick gain.

The latest evidence?

Harvest Health and Recreation (CSE: HARV, OTC: HRVSF), one of the largest cannabis companies in the U.S., jumped 35% in five days after announcing it was being bought by Trulieve Cannabis (CSE: TRUL, OTC: TCNNF), also a cannabis giant in the U.S.

Shares of Harvest responded with a big rally. Shares jumped 35% in five days. Continue reading “Columbia Care (CSE: CHWF, OTC: CHWBF): The Next 35% Gain in 2 Days?”

GW Pharma Responds: ‘Not Creating a Monopoly’

British drug manufacturer GW Pharma and its American subsidiary, Greenwich BioSciences, have responded to Leafly’s report last week about the company’s attempts to move proprietary cannabidiol (CBD) bills through at least two state legislatures.

GW/Greenwich says it is not opposing medical marijuana or CBD access. Continue reading “GW Pharma Responds: ‘Not Creating a Monopoly’”